New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia
Abroad (travel likely)RecruitingPHASE2
Conditions
BPH (Benign Prostatic Hyperplasia) · Lower Urinary Track Symptoms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Study leads
Aria Olumi, MD
Principal Investigator
Beth Israel Deaconess Medical Center